2019
DOI: 10.2298/bah1901049p
|View full text |Cite
|
Sign up to set email alerts
|

Detection of enrofloxacine residues by microbiological screening method

Abstract: The usage of microbiological screening tests is widespread in control of presence of antimicrobial drug residues in meat samples. Screening tests must be capable to detect antimicrobial drug residue of interest and detection limits must comply with MRL (Maximum Residue Limit). The aim of this study was to examine the performance of a microbiological screening test with E. coli as test microorganism: capability of detecting enrofloxacina and it's main metabolite ciprofloxacine at MRL levels in both fortified an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 11 publications
0
1
0
Order By: Relevance
“…In addition, enrofloxacin, as a fluoroquinolone medication for animals, kills microscopic organisms by reproducing the DNA of tissue bacteria 2,3 Enrofloxacin can be mixed with additional antimicrobial specialist chemicals to kill pathogenic microorganisms, and there is no cross-opposition amid different anti-toxins. In previous studies on the treatment of Legionella pneumophila, fluoroquinolone anti-infection agents have likewise been utilized in conjunction with macrolides 4 and for the treatment of bacteremia brought about by Gram-negative bacilli in combination with betalactam antimicrobials 5 . Fig.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, enrofloxacin, as a fluoroquinolone medication for animals, kills microscopic organisms by reproducing the DNA of tissue bacteria 2,3 Enrofloxacin can be mixed with additional antimicrobial specialist chemicals to kill pathogenic microorganisms, and there is no cross-opposition amid different anti-toxins. In previous studies on the treatment of Legionella pneumophila, fluoroquinolone anti-infection agents have likewise been utilized in conjunction with macrolides 4 and for the treatment of bacteremia brought about by Gram-negative bacilli in combination with betalactam antimicrobials 5 . Fig.…”
Section: Introductionmentioning
confidence: 99%